Results 81 to 90 of about 5,663,878 (222)
Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease
Abstract The mineralocorticoid receptor (MR) has a multifaceted role in normal physiologic functions. However, research has uncovered the deleterious consequences of overactivation of the MR. It has been implicated in chronic kidney disease (CKD) via its strong association with glomerulosclerosis, interstitial fibrosis, proteinuria, and decline in ...
Amy K. Mottl +2 more
wiley +1 more source
Aldosterone status associates with insulin resistance in patients with heart failure-data from the ALOFT study [PDF]
<b>Background</b>: Aldosterone plays a key role in the pathophysiology of heart failure. In around 50% of such patients, aldosterone 'escapes' from inhibition by drugs that interrupt the renin-angiotensin axis; such patients have a worse ...
Freel, E.M. +8 more
core +1 more source
Primary Aldosteronism in Patients in China With Recently Detected Hypertension.
BACKGROUND A total of 44.7% adults in China have hypertension, but the prevalence of primary aldosteronism (PA) in Chinese hypertensive patients is unknown.
Zhixin Xu +12 more
semanticscholar +1 more source
ABSTRACT Adrenal venous sampling (AVS) is the gold standard for identifying aldosterone‐producing adenoma and bilateral adrenal hyperplasia. This study reports the success rate of AVS and the distribution characteristics of the right adrenal vein orifice (RAVO). The data of 166 patients with primary hyperaldosteronism who underwent AVS in Fuwai Central
Min‐Fu Bai +6 more
wiley +1 more source
Within-patient reproducibility of the aldosterone: renin ratio in primary aldosteronism.
The plasma aldosterone concentration:renin ratio (ARR) is widely used for the screening of primary aldosteronism, but its reproducibility is unknown. We, therefore, investigated the within-patient reproducibility of the ARR in a prospective multicenter ...
Letizia C. +45 more
core +1 more source
The Evolution of the Primary Aldosteronism Syndrome: Updating the Approach.
CONTEXT New approaches are needed to address the evolution of the primary aldosteronism syndrome and to increase its recognition. Herein, we review evidence indicating that primary aldosteronism is a prevalent syndrome that is mostly unrecognized, and ...
A. Vaidya, R. Carey
semanticscholar +1 more source
CXCR4 functions as a potential cancer stem cell‐associated marker linked to chemoresistance in ovarian cancer, and an inhibitor of CXCR4, AMD3100, can enhance the cytotoxic response to cisplatin. Based on these findings, [68Ga]Ga‐Pentixafor positron emission tomography enables selective visualization of CXCR4‐high ovarian cancer, while AMD3100 combined
Lixia Feng +12 more
wiley +1 more source
Treatment of Primary Aldosteronism with mTORC1 Inhibitors [PDF]
mTORC1 activity is often increased in the adrenal cortex of patients with primary aldosteronism and mTORC1 inhibition decreases aldosterone production in adrenocortical cells, suggesting the mTORC1 pathway as a possible target for treatment of primary ...
Seelig, Eleonora +19 more
core +1 more source
Supplemental Digital Content is available in the text. Primary aldosteronism (PA) was considered a rare disorder almost always associated with hypokalemia. The widespread screening of patients with hypertension unveiled an increased prevalence of PA with
J. Burrello +11 more
semanticscholar +1 more source

